New growth formula
The US market remains choppy but Natco Pharma is becoming a compelling bet by rebooting itself with a new strategy
Prathamesh Mulye - November 04, 2019
The Outperformers (51-60)
These companies have been ranked based on their stock's excess return over the Sensex for a five-year period
September 03, 2019
Cherry-Picking Fallen Angels — Part 2
Here is a list of stocks that have fallen in the small and mid-cap carnage despite reporting robust numbers
Prathamesh Mulye - July 19, 2018
Ajay Relan
His bet on Natco Pharma’s differentiated product portfolio paid off while Monnet Ispat taught him to be wary of over-ambitious entrepreneurs
Krishna Gopalan - September 18, 2017
Self-healing
Hyderabad’s pharma players are adapting to a regulatory backlash and fighting back against dumping from China
Krishna Gopalan - March 09, 2016